Drugs / quadrivalent subunit influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07710586 | Nov 2024 → May 2025 | — | Ab&B Bio-tech Co., Ltd.JS | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | quadrivalent subunit influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07710586 ↗ |
| Modality | Vaccine | “quadrivalent subunit influenza vaccine” NCT07710586 ↗ |
| Route | Intramuscular | “0.5 mL intramuscular dose” NCT07710586 ↗ |